Advancements in molecular engineering due to the emergence of new cell technologies in biotechnological industries is augmenting the growth of the market studied. Furthermore, continuous support from the government in advancing the DNA technologies and growing demand for cloned products expected to boost the market growth over the forecast period. In addition, combining the artificial intelligence in developing the products, growing research and development on DNA technologies in research institution are projected to bolster the market growth. Moreover, the need for advanced products for the treatment of diseases and favourable regulatory policies are supplementing the market growth. However, very high cost of research and development of competent cells coupled with market consolidation are expected to hamper the market growth over the period.

Key Market Trends

Cloning Application Expected to Register Significant Growth Rate

  • Cloning, in the application segment is projected to grow at significant rates owing to the high demand for molecular cloned products. Furthermore, the increase in research on cloning and financial support form various agencies for research is expected to boost the segment growth.
  • The biotechnology segment is projected to witness a notable growth rate due to rising investments in R&D and commercialization of proteomics and genomic-based products. Furthermore, the need for advanced product technologies in the treatment of various diseases are projected to bolster segment growth.
  • In addition, increased funding on studies for DNA cloning technologies in academic research institutions and use of these products in therapeutics is anticipated to strengthen the market growth in the near future.



North America and Europe are the Major Markets

North America and Europe markets are anticipated to have a majority of the share globally. The growth is attributed to extensive studies on DNA cloning technologies in the regions and the presence of key market players. Furthermore, favorable reimbursement policies coupled with increased investment from public and private companies is anticipated to boost the market growth in the North America region. Moreover, the advent of innovative technologies in developed regions and the need for commercial cloning products for therapeutic uses is predicted to aid the market share over the forecast period. The Asia Pacific region is anticipated to have a significant growth rate owing to the developing healthcare and research infrastructure especially in emerging countries of the region.

Competitive Landscape

The competent cells market is moderately consolidated having a notable number of market players. Companies are focusing on developing new technologies in cell DNA cloning and broadening the applications of competent cells. The key market players operating in the market include Thermo Fisher Scientific, Merck KGaA, Promega Corporation, Takara Bio Inc. and Agilent Technologies, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client’s requirements
  • 3 months of analyst support